Rilpivirine D6
Product Description
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
Categories
Specifications
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
More Products from CLEARSYNTH LABS LIMITED (42)
-
Product Cis-2,3 dihydrotetrabenazine 13C2 D6
Labeled Tetrabenazine, intended for use as an internal standard for the quantification of Tetrabenazine by GC- or LC-mass spectrometry. -
Product Clobetasol D5
Labelled Clobetasol. Topical corticosteroid. Glucocorticoid; anti-inflammatory.;Labeled Clobetasol, intended for use as an internal standard for the quantification of Clobetasol by GC- or LC-mass spectrometry. -
Product Clindamycin 13C D3 Hydrochloride
Labeled Clindamycin, intended for use as an internal standard for the quantification of Clindamycin by GC- or LC-mass spectrometry. -
Product Clopidogrel D4 Hydrogen sulfate
Labeled Clopidogrel, intended for use as an internal standard for the quantification of Clopidogrel by GC- or LC-mass spectrometry. -
Product Clopidogrel D3 Hydrochloride
Labeled Clopidogrel, intended for use as an internal standard for the quantification of Clopidogrel by GC- or LC-mass spectrometry. -
Product Clopidogrel D3 Hydrogen sulphate
Labeled Clopidogrel, intended for use as an internal standard for the quantification of Clopidogrel by GC- or LC-mass spectrometry. -
Product Sildenafil D3
Labeled Sildenafil, intended for use as an internal standard for the quantification of Sildenafil by GC- or LC-mass spectrometry. -
Product Diatrizoic acid
Molecular formula: C11H9I3N2O4Molecular weight: 613.91 -
Product Dipyridamole D20
Selective inhibitor of phosphodiesterase V (PDE 5); potent coronary vasodilator drug; adenosine transport inhibitor; inhibitor of platelet aggregation.;Labeled Dipyridamole, intended for use as an internal standard for the quantification of Dipyridamole by GC- or LC-mass spectrometry. -
Product Raloxifene D4
Deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist.;Labeled Raloxifene, intended for use as an internal standard for the quantification of Raloxifene by GC- or LC-mass spectrometry. -
Product 5-Hydroxy Propafenone Hydrochloride D5
Labeled Propafenone, intended for use as an internal standard for the quantification of Propafenone by GC- or LC-mass spectrometry. -
Product Raloxifene Hydrochloride
A nonsteroidal, selective estrogen receptor modulator (SERM). Antiosteoporotic.
CLEARSYNTH LABS LIMITED resources (1)
-
Video Clearsynth Intro Video
Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.











